Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Q4 2023 Earnings Call Transcript March 28, 2024
Zevra Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.4 EPS, expectations were $-0.2. ZVRA isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).
Operator: Good afternoon, everyone. Thank you for joining the Zevra Therapeutics’ Q4 2023 Corporate Updates and Financial Results Call. Today’s call is being recorded. It will be...
